IMPLANTABLE VENTRICULAR ASSIST SYSTEM AND METHOD OF OPERATION THEREOF - Patent application

Abstract

The present invention relates to a method for operating an implantable ventricular assist system (2), comprising the steps of: a) determining a first impedance parameter at a first time point by the assist system (2); b) determining a second impedance parameter at a second time point by the assist system (2); and c) using at least the first impedance parameter and the second impedance parameter to determine a change in impedance parameter or comparing at least the first or second impedance parameter to a threshold value. [Selected Figure] Figure 2

Description

[Technical field]

[0001] The present invention relates to an implanted ventricular assist system, its processing unit and a method for operating an implantable ventricular assist system. The present invention is particularly used for (totally) implanted left ventricular assist systems (LVAD [Left Ventricular Assist Device]). [Background technology]

[0002] Implanted left ventricular assist systems (LVADs) exist in two main design variants. On the one hand, there are (percutaneous) minimally invasive left ventricular assist systems. The second variant is a left ventricular assist system that is invasively implanted under the rib cage. The first variant circulates blood from the left ventricle directly to the aorta, as the (percutaneous) minimally invasive left ventricular assist system is located in the center of the aortic valve. The second variant circulates blood from the apical region from the left ventricle to the aorta via a bypass tract.

[0003] The task of the cardiac assist system is to circulate blood. The so-called cardiac time volume (usually expressed in liters per minute, Herz-Zeit-Volumen [HTV]) is of high clinical relevance in the present case. In other words, the cardiac time volume influences the total volumetric flow of blood from the ventricles, especially the left ventricle, into the aorta. The initial task is therefore to determine this parameter as a measurement while the cardiac assist system is working.

[0004] Depending on the level of assistance, which represents the proportion of the volumetric flow from the ventricles to the aorta that is delivered by circulatory means such as the pump of the assistance system, a certain volumetric flow reaches the aorta via the physiological pathway through the aortic valve. Thus, the cardiac time volume or the total volumetric flow from the ventricles to the aorta (Q HTV ) is usually expressed as the pump volume flow rate (Q p ) and aortic valve volume flow (Q a ) is the sum of

[0005] In clinical practice, cardiac time volume (Q HTVEstablished methods for determining pump volumetric flow (Q) are the use of dilution techniques, but all rely on percutaneously inserted catheters and can only provide cardiac time-volume measurement data during cardiac surgery. p Established methods for measuring the activity of the assistive system are the correlation of its operating parameters, mainly power consumption, possibly supplemented by further physiological parameters such as blood pressure. It has also already been proposed to incorporate dedicated ultrasound measurement techniques into the assistive system.

[0006] Specifically, the cardiac time volume, i.e., Q HTV (Fully) embedded recording of has not yet been proposed or implemented. In this case, fully embedded means in particular that the means required for recording are entirely inside the patient's body and remain there. This would make it possible to record cardiac time volumes even outside of cardiac surgery.

[0007] Impedance cardiography is a method for determining the so-called cardiac output using external impedance measurements. Four electrodes are used. A small alternating current is supplied by two electrodes and the resulting voltage drop is measured by two additional electrodes. Because blood has a higher electrical conductivity than the surrounding tissue, blood volume changes in the thorax can be detected as impedance changes over the cardiac cycle, especially compared to air-filled lungs. Impedance cardiography is usually used externally, using ring or adhesive electrodes around the neck and abdomen.

[0008] It is also known to use left ventricular impedance together with the electrocardiogram to detect abnormal mechanical contractions of the myocardium in LVAD patients. In this case, an intracardiac ECG is combined with a left ventricular impedance measurement to detect abnormal contractions of the ventricles. The measurements are synchronized by the ECG. The measurements are qualitative and no volume is determined.

[0009] The use of impedance measurements for quantitative volume determination is known in the area of ​​bladder volume. Four electrodes are used on the outside of a catheter, which is inserted into the bladder only for measurement purposes and then removed again. The measured impedance has been shown to be inversely proportional to the bladder volume. However, a problem with this method is its strong dependence on the conductivity of urine. Summary of the Invention

[0010] On this basis, the present invention is based on the task of further improving the method for operating an implanted ventricular assist system for recording special parameters and of specifying a corresponding advantageous system.

[0011] To achieve this task, the feature combinations specified in the independent claims are proposed. Advantageous configurations and further developments of the invention are given in the dependent claims.

[0012] A method for operating an implanted ventricular assist system includes: a) determining a first impedance parameter at a first time using an auxiliary system; b) determining a second impedance parameter at a second time point using an auxiliary system; and c) using the first impedance parameter and the second impedance parameter to determine at least a change in the impedance parameter or comparing at least the first or second impedance parameter with a threshold value, as proposed in the present specification according to claim 1.

[0013] The assist system preferably serves the purpose of circulating a fluid. The ventricular assist system is preferably a cardiac assist system. The method preferably serves to determine the total fluid volume flow rate (through a cross section within the area of ​​the assist system) from the ventricles of the heart, in particular from the (left) ventricle of the heart to the aorta in the area of ​​the (fully) implanted (left) ventricular (cardiac) assist system, and / or to determine the aortic valve or bypass volume flow rate flowing through the assist system. The fluid is usually blood. The assist system is preferably placed at the left ventricle of the heart or at the outlet of the left ventricle. The assist system is preferably placed in particular at the aortic valve position. In particular, the total volume flow rate is defined as the total volume flow rate through a vessel or through a cross section of a vessel. The vessel is for example the aorta, in particular in the case of a left ventricular assist system, or the pulmonary trunk (Truncus pulmonalis) to the two pulmonary arteries, in particular in the case of a right ventricular assist system. The method is particularly useful for determining the total cardiac time volume (equation symbol Q) of a patient with a left ventricular cardiac assist system (LVAD) implanted in the (fully) aortic valve position and / or via the assist system itself. HTV The present invention is particularly suitable for determining the HTV having the following structure:

[0014] The method is based in particular on the integration of ventricular impedance measurements, in particular impedance spectroscopy, into a (left) ventricular (cardiac) assist system (LVAD), preferably for determining the cardiac time volume (HTV) and / or the aortic valve or bypass volume flow. Furthermore, the procedure may contribute to the determination of the level of assistance. The method advantageously allows the cardiac time volume and / or the bypass volume flow to be provided outside of a surgical scenario, with a quality comparable to the use of a dilution catheter. This allows the cardiac time volume (Q HTV ) whereas the more commonly used pump volumetric flow rate (Q p This is particularly advantageous since it has a higher clinical relevance than conventional methods. The solution proposed here is characterized in particular by the use of a sensor tightly integrated in the LVAD, for example without the need for a separate ultrasound cuff around the aorta.

[0015] In step a), (at least) a first impedance parameter is determined by the auxiliary system at a first time point. The first ventricular volume is preferably determined at the first time point in step a) by an impedance measurement by the auxiliary system or by the first impedance parameter. In other words, this means in particular that the auxiliary system itself measures and determines, in particular, the impedance parameter or the ventricular volume. In step b), (at least) a second impedance parameter is determined at a second time point by the auxiliary system. The second ventricular volume is preferably determined at the second time point in step b) by an impedance measurement by the auxiliary system. In other words, this means in particular that in steps a) and b), at least one impedance parameter and / or one ventricular volume is determined over time. The first and second time points are different from each other. The second time point is preferably after the first time point. Several impedance parameters or ventricular volumes can be determined at other time points. A short gap between the time points is particularly advantageous for forming a difference for determining the volumetric flow rate. The ventricular volume is limited in particular by the ventricular wall or sac-shaped ventricular cavity wall and by the heart valve, one of which is also called the aortic valve. The ventricular volume is essentially determined by the volume of fluid (here in particular the volume of blood) in the ventricle. The difference in ventricular volume results in particular from the contraction of the myocardium, which normally contributes to the circulation of blood by the cardiovascular system of the human or, where applicable, patient.

[0016] The impedance parameter may for example be the (bio) impedance of the fluid and / or tissue in the region of the auxiliary system. The raw data of the analogue / digital converter (unitless values) of the impedance measuring device may also serve as impedance parameter. The impedance parameter is preferably the ventricular impedance. In other words, this means in particular that the ventricular impedance is determined in steps a) and b). The ventricular impedance is usually a function of the ventricular volume, in particular the amount of fluid in the ventricle, and the fluid conductivity (in particular the blood conductivity). Furthermore, the muscle surrounding the ventricle may also provide an impedance element. The influence of the blood conductivity can be determined by a separate impedance measurement in a known sample volume. In particular, measurements at a defined volume of the (entrance) cannula are candidates in this case. The impedance measurement serves in particular to determine the change in the ventricular pulsatile volume during systole. In an advantageous embodiment, the impedance data can be verified by pressure sensor data.

[0017] It is particularly preferred that the impedance of the (volume unknown) ventricle is determined by electrodes in and / or integrated into the auxiliary system. The electrodes (for measuring the ventricular impedance) are preferably arranged on or in a surface, in particular on or in an outer surface (circumferentially) of the auxiliary system. It is particularly preferred that the electrodes are arranged on or in an outer surface (circumferentially) of the (inlet) cannula of the auxiliary system.

[0018] In step c), the change (over time) of the impedance parameter is determined using the first impedance parameter and the second impedance parameter. Step c) can alternatively or cumulatively compare at least the first or second impedance parameter with a threshold value. The change (over time) of the ventricular impedance is preferably determined using the first impedance parameter and the second impedance parameter. The threshold value is preferably a (pre)defined and / or constant threshold value. The threshold value can be specifically specified and determined, for example by means of calibration (in vivo), as a particularly low threshold value for the impedance parameter or the corresponding raw data value. The low threshold value is set in particular so as to avoid ventricular collapse and / or suction effects, which lead to suction of the assist system to the ventricular wall. Step c) can preferably determine the change (over time) of the ventricular volume using the first impedance parameter and / or the first ventricular volume, and the second impedance parameter and / or the second ventricular volume. Step c) can alternatively or cumulatively compare the first and / or the second impedance parameter and / or the ventricular volume with a minimum ventricular volume. The change in impedance parameter or ventricular volume is determined in particular when the assist system is implanted in a patient with partial assistance (low to high assistance level). The comparison with the threshold or minimum ventricular volume is performed in particular when the assist system is implanted in a patient with full assistance (assistance level = 100%). If only one comparison with the threshold or minimum ventricular volume is performed, one of steps a) or b) can be omitted. In addition, the determination and comparison of the change can also be performed cumulatively, in particular simultaneously or at least partially in parallel, for example in a short-term (full) assisted patient in the recovery phase. Alternatively or cumulatively, a high threshold or maximum ventricular volume can be specified for comparison against a low threshold or minimum ventricular volume. The high threshold and / or minimum ventricular volume are set in particular so as to avoid excessive loads, in particular dilation of the ventricular wall.

[0019] In patients with partial assistance, the changes in impedance parameters or ventricular volumes during systole (cardiac contraction or blood outflow phase) can contribute to the transport of blood through the cardiovascular system, in other words to the maintenance or increase of the total fluid volume from the ventricle or the cardiac time volume. In these patients in particular, the determination of the changes in impedance parameters or ventricular volumes is particularly important. The pulsatile impedance parameters or ventricular volume changes are preferably determined during systole. In other words, this means that, in particular, in step c), the changes in impedance parameters or ventricular volumes (induced by the pulse or by the muscles) are preferably determined during systole. It is particularly preferred that the difference between the impedance parameters or ventricular volumes is determined at the beginning of systole and that the difference between the impedance parameters or ventricular volumes is determined at the end of systole. For this purpose, the first time point can be, for example, the beginning of systole and the second time point the end of systole. However, in this exemplary illustration, it must be taken into account that the sampling rate of the impedance parameters or ventricular volumes should be high enough to satisfy the Nyquist theorem of the expected ventricular contraction, for example 60 1 / s.

[0020] In patients receiving full assistance (especially with a continuously operating assistance system), the changes in the impedance parameter or the ventricular volume play in particular a rather subordinate role. Rather, in these patients, care must be taken that the impedance parameter or the ventricular volume does not fall below a low threshold or a minimum ventricular volume. The minimum ventricular volume is preferably a defined or predetermined and / or constant minimum ventricular volume. The minimum ventricular volume is set in particular such that ventricular collapse and / or suction effects, which lead to suction of the assistance system to the ventricular wall, can be avoided. The comparison can be performed in the processing unit. For this purpose, the measuring device can provide the (first and / or second) impedance parameter or the (first and / or second) ventricular volume as initial values ​​for the processing unit. The impedance parameter or the ventricular volume can represent a control parameter of the assistance system, which is preferably kept above a low threshold or a minimum ventricular volume. Furthermore, the impedance parameter relative to a threshold or the ventricular volume relative to a minimum ventricular volume difference can represent a control parameter of the assistance system. The processing unit of the auxiliary system can provide this control parameter as an output parameter, in particular as an output parameter of a control unit of the auxiliary system, which preferably adjusts the power of the electric motor of the auxiliary system and therefore also in particular the (blood) circulation volume of the auxiliary system. For example, the circulation volume of the auxiliary system can be reduced if there is a risk of ventricular wall aspiration. Furthermore, the circulation volume of the auxiliary system can be increased, for example, if there is a risk of ventricular wall overstretching.

[0021] In particular, if several impedance parameters or ventricular volumes are determined in steps a) and b), it is particularly advantageous for at least one model graph to be adjusted to the impedance parameters or ventricular volumes, in which case it is also preferred if processing continues with the model parameters or the at least one model graph.

[0022] According to an advantageous embodiment, it is proposed that the ventricular volume is determined by means of (respectively) impedance parameters. In other words, this means, in particular, that an impedance measurement is performed to determine the ventricular volume or that the ventricular volume is determined from an impedance measurement. Preferably, a first impedance parameter is used to determine the first ventricular volume and a second impedance parameter is used to determine the second ventricular volume.

[0023] According to a further advantageous embodiment, it is proposed that the (respective) impedance parameter is measured by at least two electrodes arranged on the auxiliary system. It is particularly preferred that the first and second impedance parameter (respective ventricular impedance) are measured by at least two, advantageously four, electrodes. For this purpose, (smaller) patient auxiliary currents, for example 50 kHz, 100 μA (AC), can be used for the measurement. The electrodes are also preferably spaced from one another such that their detection range or detection volume includes the ventricular volume. The detection range or detection volume in particular relates to the area or volume covered by the current path between the electrodes. In other words, it in particular relates to the area or volume through which the current path extends between the electrodes. The at least two electrodes preferably comprise at least two electrode pairs, in particular each comprising a current electrode and a voltage measurement electrode. The electrodes of a pair should be placed close to each other. However, the pairs should be separated from each other. An arrangement in which the current electrodes are located on the outside and the voltage measurement electrodes on the inside (in the form of a four-wire measurement) is advantageous. The detection range or detection volume generally increases with increasing distance between the electrode pairs. The distance is preferably determined such that the entire volume of the ventricle can be detected as far as possible, but the surrounding tissue and / or organs, in particular the lungs, are as far as possible out of the detection range.

[0024] According to a further advantageous embodiment, it is proposed that the impedance measurement is carried out at different (alternating) frequencies, in particular for determining the first and / or second impedance parameters. This can advantageously contribute to a reduction in the influence of the surrounding tissue, in particular the myocardium, on the impedance measurement. Particularly preferably, (bio)impedance spectroscopy is carried out. Preferably, the frequency is selected such that the background impedance of the myocardium can be or is determined, particularly preferably periodically. This background impedance can be taken into account for the impedance measurement of the ventricular volume.

[0025] According to an advantageous embodiment, it is proposed that the conductivity of the fluid is determined by impedance measurements in a defined volume of the auxiliary system. This contributes in particular to the fact that the auxiliary system itself can determine the conductivity of the fluid, which influences the impedance measurements. The defined volume is preferably arranged in an (entrance) cannula of the auxiliary system. The defined volume is preferably limited in particular by the inner surface or a part of the inner surface of the cannula of the auxiliary system. Furthermore, the defined volume (in the direction along the cannula) can be limited by two electrodes. Preferably, at least one of the (limiting) electrodes is in this case arranged on or in the inner surface of the cannula. Furthermore, it is preferred that at least two, advantageously four, electrodes are arranged for the conductivity measurement on or in the inner surface of the cannula (circumferential direction).

[0026] According to an advantageous embodiment, it is proposed that the fluid volume flow through the auxiliary system is also determined. In other words, this relates in particular to the fluid volume flow only through the auxiliary system itself. The fluid volume flow is usually not limited to the so-called pump volume flow (Q p This value is the total volumetric flow or cardiac time volume (Q HTV ), the so-called level of assistance is Q p Q HTV (i.e., QP / Q HTV ) to determine the pump volume flow rate. The established methods described above in relation to the prior art can be used to measure the pump volume flow rate. For example, the pump volume flow rate can be determined based on the differential pressure and the motor characteristic field or by explicit Doppler ultrasound measurements. The pump volume flow rate is preferably determined by an ultrasound sensor, which can be housed, for example, at the tip of the auxiliary system. A fluid volume flow rate graph versus time or pump volume flow rate is preferably determined. The latter can be compared to a total fluid volume over time graph. The level of assistance can be provided as a control parameter of the auxiliary system.

[0027] According to an advantageous embodiment, it is proposed that the total fluid volume flow is determined in the region of the assist system. The total fluid volume flow is preferably determined using the first and second ventricular volumes. If the total fluid volume flow essentially corresponds to a time-related function of the ventricular volumes, the total fluid volume flow can be determined (approximately) in the form of a difference ratio, which is the ratio (ΔV / Δt) of the ventricular volume difference (ΔV=second ventricular volume-first ventricular volume) to the time difference (Δt=second time point (e.g., end of systole)-first time point (e.g., start of systole)). If the total fluid volume flow essentially corresponds to a time-related function of the ventricular volumes, this may occur in particular in low-assistance levels and / or pulsatile-operation assist systems, for example controlled by ventricular pressure sensors or ECG sensors. Furthermore, an estimate of the total cardiac time volume (HTV) can also be made using the measured pump volume flow and the measured ventricular volumes. Preferably, the total fluid volume flow or cardiac time volume is calculated by sampling the ventricular volume and the fluid volume flow or pump volume flow versus time. The total fluid volume flow or cardiac time volume (Q HTV ) is generally (at least for continuous assist systems) calculated as the function of the change in ventricular volume versus time (δV / δt) and the basal pump volumetric flow (Q P,Diastole ) can be determined from the following relationship between

number

[0028] The determined total fluid volume flow rate is preferably provided as a control parameter of the auxiliary system. A processing unit of the auxiliary system can provide this control parameter as an output parameter, in particular as an output parameter of a control unit of the auxiliary system, which preferably adjusts the power of the electric motor of the auxiliary system and thus also in particular the (blood) circulation volume of the auxiliary system.

[0029] In addition, the aortic valve or bypass volume flow (Q A ) is preferably determined. Particularly preferably, the bypass flow (aortic valve or bypass volume flow) is quantified as bypass to the assist system and bypass through the aortic valve by the ventricular volume change and the pump volume flow:

number

[0030] The bypass volume flow rate may be provided as a control parameter for the auxiliary system.

[0031] According to a further aspect, a processing unit is proposed, configured to perform the method proposed herein. The processing unit may include a microprocessor having access to a memory. The processing unit preferably receives data from the measurement device.

[0032] According to a further aspect of the present invention there is provided an implantable ventricular assist system, comprising: - a measurement device configured to determine a first impedance parameter at a first time point and a second impedance parameter at a second time point; - a processing unit configured to use at least the first impedance parameter and the second impedance parameter to determine a change in the impedance parameter (over time) or to compare at least the first or second impedance parameter with a threshold value.

[0033] The assist system is preferably a left ventricular assist system (LVAD) or a percutaneous minimally invasive left ventricular assist system. Furthermore, it is preferred that the assist system can be fully implanted. In other words, this means in particular that the means required for sensing, in particular the impedance sensor and / or the pump volume flow sensor, are located and remain completely inside the patient's body. It is particularly preferred that the assist system is preferably adapted to be placed at least partially in a ventricle, preferably in the left ventricle of the heart, and / or in the aorta, in particular at the aortic valve position.

[0034] Furthermore, the auxiliary system preferably comprises a cannula, in particular an inlet cannula, a pump and / or a flow machine such as an electric motor. The electric motor is usually a component of the flow machine. The (inlet) cannula is preferably arranged so that, in the implanted state, it is able to direct fluid from the (left) ventricle of the heart to the flow machine. The auxiliary system is preferably elongated and / or tubular. The inlet cannula and the flow machine are preferably arranged in regions at both ends of the auxiliary system.

[0035] According to an advantageous embodiment, it is proposed that the measuring device comprises at least two electrodes with which the impedance can be measured. For the measurement of the ventricular impedance, preferably at least four electrodes are provided. Particularly preferably, the electrodes are configured and arranged in such a way that the impedance of the (total) ventricle can be determined.

[0036] The details, features and advantageous embodiments discussed in relation to the method may occur accordingly in the processing unit presented herein and / or in the auxiliary system, and vice versa. In this regard, reference is made in full to the description thereof for a more detailed description of the features.

[0037] The solutions presented herein and their technical environment are described in detail below with reference to the figures. It should be noted that the present invention is not limited by the illustrated exemplary embodiments. In particular, unless otherwise expressly stated, it is also possible to extract partial aspects of the facts described in the figures and combine them with other components and / or insights from other figures and / or this description. The following is a schematic diagram: [Brief description of the drawings]

[0038] [Figure 1] FIG. 1 illustrates an implantable assist system. [Diagram 2] FIG. 2 shows a ventricular assist system implanted in the heart. [Diagram 3] FIG. 3 shows the auxiliary system of FIG. [Figure 4] FIG. 4 shows an implanted ventricular assist system. [Diagram 5] FIG. 5 shows a schematic process diagram of the described method. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0039] 1 shows a schematic representation of an implantable assist system 2, which in this case is an example of a left ventricular assist system (LVAD). The assist system 2 comprises a tip 10, which may contain sensors, an inlet cage 11 with an inlet opening 12 for drawing in a fluid (here, blood), a flexible cannula 13, an impeller cage 14 with a turbine wheel (not shown here) and an outlet opening 15 for blood, an electric motor 16, a rear end 17 (so-called back end) which may accommodate sensors, and a connecting cable 18.

[0040] FIG. 2 shows a schematic representation of an implanted ventricular assist system 2 in a heart 19. The assist system 2 assists the heart 19 by assisting the circulation of blood from the (left) ventricle 20 to the aorta 21. For this purpose, as shown in FIG. 2, the assist system 2 is fixed within the aortic valve 22. At an assist level of 100%, the assist system 2 (LVAD) circulates the full volumetric flow of blood. The assist level represents the proportion of the volumetric flow circulated by or through the conveying means, such as a pump, of the assist system 2 to the total volumetric flow of blood from the ventricle 20 to the aorta 21.

[0041] At a level of 100% assistance, the total fluid volume flow 1 from the ventricle 20, the cardiac valve volume flow 23 to the ventricle 20, and the fluid volume flow 7 through the assistance system 2 are therefore identical. The aortic valve or bypass volume flow 24 (equation symbol Q a ) is zero. The total fluid volume flow 1 is calculated by the (total) cardiac time volume (HTV: Q HTV The fluid volume flow 7 may also be described as the so-called pump volume flow (symbol Q p ) The level of assistance can therefore be expressed as Q P / Q HTV It can be calculated from the ratio of

[0042] In the case of a healthy heart with low levels of assistance and strong ventricular contractions, the heart 19 continues to perform its function to some extent, so that a pulsatile volumetric flow fraction 24 (bypass) through the heart or aortic valve 22 is generated during systole (the myocardium contracts, reducing the volume of the ventricles 20, thereby shifting blood to the aorta 21). At the same time, the pressure difference over the assistance system 2 is reduced, in particular over the pumps (not shown here) normally provided by the assistance system 2, and therefore the assistance system 2 also carries an increased fluid volumetric flow 7 during systole.

[0043] The solution proposed here is based on detecting the change in ventricular volume over time, in particular by impedance measurements. Then, the known (or recorded over time) fluid volume flow 7 or pump volume flow (Q p ), the otherwise nearly unmeasurable aortic valve or bypass volume flow 24 can be advantageously quantified by determining the difference.

[0044] FIG. 3 shows the auxiliary system 2 of FIG. 2 in a schematic way. To determine the ventricular volume at a certain point in time, FIGS. 2 and 3 show a realization by (left ventricular) intracardiac impedance measurement. Impedance measurement has the advantage that the measurement of the total volume and electrical resistance of the fluid or liquid can be carried out with relatively simple technical means. By using four electrodes 4, 5, 27 and 28 (four-wire measurement), as in the example shown here, the impedance measurement is hardly dependent on the contact resistance of the measurement electrodes, so that the measurement results are also suitable for long-term implantation in the patient. In this case, the electrodes 4, 5, 27 and 28 form an exemplary measuring device 9 of the auxiliary system 2. FIG. 3 also illustrates by way of example that an ultrasound-based pump volume flow sensor 25 can be integrated into the tip 10. The pump volume flow sensor 25 measures the fluid volume flow 7 and / or the pump volume flow (Q p ) can be detected and provided over time.

[0045] For impedance measurements, at least two electrodes 4, 27 should be incorporated in an area of ​​the ventricle 20 such that the current path 26 of the measurement current can record the ventricular volume as best as possible. Areas of the inlet cage 11 are suitable for this purpose, for example proximal and / or upstream and distal and / or downstream of the inlet opening 12. At least two electrodes 4, 27 are technically required to close the electric circuit. The use of four electrodes 4, 5, 27 and 28 is advantageous, since the influence of the contact impedance from the electrodes to the blood is negligible, and long-term changes in the electrode surface therefore have no or only a very small influence on the measurement result. For example, it is preferred that the current electrodes 4, 27 are arranged on the outside, and the voltage measurement electrodes 5, 28 between them. In this case, the current path 26 extends from electrode 4 to electrode 27 (current electrode). Equipotential lines, not shown here, are formed between them and can be measured at high resistance by the voltage electrodes 28 and 5.

[0046] Since the amount of detection depends, inter alia, on the distance of the measurement pairs (4 and 28 to 5 and 27), it is advantageous to place one pair 4, 28 as distal as possible or in the region of the tip 10 and one pair 5, 27 as proximal as possible or towards the electric motor 16 of the auxiliary system 2. In this case, it is advantageous for the measurement quality if all four electrodes 4, 5, 27 and 28 are still placed in the region of the ventricle 20 and the proximal pair 5, 27 does not move beyond the aortic valve plane into the aorta 21, and based on this design measurements are also conceivable or feasible.

[0047] The measured electrical conductivity between the electrode pair is a function of the surrounding fluid or fluid volume and its conductivity. Since the ion concentration in blood is kept within a narrow range by the kidneys, a predetermined and / or constant conductivity can be assumed. Nevertheless, here an explicit determination of the blood conductivity is particularly preferred. For this purpose, a defined volume 6 is required, for example present inside the (entrance) cannula 13. Thus, one to four further electrodes 29, 30, 31 and 32 can be arranged in the cannula 13 (which can also be called the entrance tube). As with the measurement of the ventricular volume, in this case the measurement can be performed by current injection and voltage measurement at the electrode pair 29 and 30 or by current injection between the electrode pair 29 and 30 and voltage measurement between the electrode pair 31 and 32. If at least one electrode 4, 5, 27 or 28 of the ventricular measurement is located in the area or close to the entrance opening 12, the pair 29, 31 may be omitted. Measurements can then be performed, for example, by current injection at electrode pair 27, 30 and voltage measurement between electrode pair 5 and 32. Since electrode pair 5, 27 is located in the area or near the inlet opening 12, a defined volume 6 results in the cannula 13 between electrode pair 5, 27 and electrode pair 30, 32. Three electrodes are therefore particularly minimally required to perform a strictly two-point measurement. By way of example, a ventricular impedance measurement is then performed between electrodes 4 and 5, and a conductivity measurement is performed between electrodes 5 and 30.

[0048] The assignment of the electrodes shown here as current electrodes or voltage measurement electrodes is merely exemplary. Current electrodes in this case are in particular electrodes that can be connected to a current source or are connected to a current source. Voltage measurement electrodes are in particular electrodes that can be connected to a voltage measurement device or are connected to a voltage measurement device. Any assignment is possible that can fulfil the purpose of the impedance measurement (of ventricular volumes and / or electrical conductivity) presented here. The voltage source and / or the voltmeter can be part of the measurement device 9. If the current source and the voltmeter are spatially separated from the auxiliary system 2 by an electrical supply line 18, the supply line cable has a particularly advantageous triaxial design with active shielding.

[0049] For measurements (of ventricular volume and / or conductivity), for example, an alternating current can be injected by current electrodes and the resulting voltage drop can be measured, for example, by voltage measuring electrodes, but a voltage can also be applied and the resulting current flow can be measured.

[0050] The measurements can be carried out at a single (alternating) frequency. Values ​​in the range of 50 kHz have been established for bioelectrical impedance analysis and impedance tomography. In addition to the blood volume, the surrounding myocardium also contributes slightly to the measured impedance. Since this is cellular material that has a different structure than the cellular material in blood, the influence can be reduced by so-called bioelectrical impedance spectroscopy. In this case, the measurements are not carried out at a fixed frequency, but at several frequencies. The result is the electrical impedance as a function of frequency (dispersion, see call chart).

[0051] For example, measurements can be performed in the range of 1 kHz to 1 MHz. Spectroscopic measurements can be performed, for example, by sequences of sinusoidal frequencies, so-called chirps, or wideband binary sequences (pseudorandom noise).

[0052] The sampling rate of the ventricular impedance should be high enough to satisfy the Nyquist theorem, for example 60 1 / s, at the expected ventricular contraction frequency. Since myocardial impedance changes are expected only very slowly, in contrast to ventricular volume changes, a sweep of the complete frequency range is not necessary for every measurement. The background impedance of the myocardium can be determined periodically. It is also advantageous to determine frequency measurement points of the background impedance over several heartbeats. For this purpose, the measurement can be performed at two frequencies with a high sampling rate. The first frequency is preferably fixed and the second frequency varies, for example, from heartbeat to heartbeat (for example, determined based on an impedance plot of the first frequency). The spectra of the separate measurements are combined, for example, using the impedance plot of the first frequency. Instead of the first frequency, it is also possible to synchronize, for example based on a pressure plot of a pressure sensor.

[0053] Figure 4 shows a schematic of an implanted ventricular assist system 2. Figure 4 illustrates the resulting volumetric flows in the heart 19. The left volume represents the ventricle or ventricular volume 3, and the right volume represents the aorta 21. By conservation of mass, the (cardiac valve) volumetric flow 23 from the left atrium to the ventricle and outflow to the aorta corresponds to the total fluid volumetric flow 1 or (total) cardiac time volume. Valvular regurgitation or hydraulic shunts between the ventricles are exceptions.

[0054] The assist system 2 (LVAD) delivers a circulatory volumetric flow 33, for example by the output of a pump (not shown) of the assist system 2. In a continuous assist system, the flow is constant, in a pulsatile assist system, this flow is time modulated. Contraction of the ventricles increases the pressure in the ventricles, reducing the pressure difference on the assist system 2, which causes the assist system 2 to deliver an additional systolic volumetric flow 34 at a constant mechanical output during systole. If the ventricular contraction is strong enough (for example, in a short-term assist patient), the ventricular pressure may exceed the aortic pressure, which causes the aortic valve to open (not shown). An additional bypass flow (equation symbol Qa) is formed, which is shown in FIG. 4 as the aortic valve or bypass volumetric flow 24. This flow portion (bypass 24) cannot be (directly) detected by a flow sensor of the assist system 2, for example an ultrasonic sensor at the tip of the assist system 2, but is essentially a function of the change in the ventricular volume δV / δt and the pump volumetric flow Q p In this case, we only quantify the flow through the auxiliary system 2 itself, the pump volume flow Q, also referred to herein as the fluid volume flow 7. p is obtained from the sum of the circulatory volume flow 33 and the systolic volume flow 34. By combining the ventricular volume measurements over time and the pump flow measurements over time, the bypass flow, i.e. the aortic valve or bypass volume flow 24 (equation symbol Q A ) can be determined according to the following formula:

number

[0055] This relationship, as well as an exemplary derivation of cardiac time volume, is illustrated using Equations 1-13 below. The equation symbols used are first briefly explained. QHTV Cardiac time volume Q P Time-dependent volumetric flow rate through a pump Q A Time-dependent volumetric flow through the aortic valve Q V Time-dependent volumetric flow into the ventricular storage volume (changes in ventricular volume) Q D Time-dependent volumetric flow from the left atrium to the aorta (Assumption: base flow through the pump) V ventricular volume t time

number

number

[0056] From (bio)impedance measurements the following is known:

number

[0057] From exemplary ultrasonic measurements the following is known:

number

[0058] Furthermore, it can be assumed that the following applies during diastole:

number

[0059] Therefore, the bypass flow rate Q A can be determined by:

number

[0060] In addition, the cardiac time volume Q HTV can be determined by:

number

[0061] Furthermore, it is also preferred to put the auxiliary system in a specific volumetric mode. In this case, the pump is adjusted by an integrated pressure sensor so that the pressures in the inlet cage and the impeller cage are identical, i.e. there is no volumetric flow, only a fast rotation of the pump, and no return flow from the aorta through the pump to the ventricle. At the same time, the cardiac output, the end diastolic blood volume, and / or the contraction strength of the ventricle can be determined based on the impedance measurement data (measured there) graph over time and / or used to control the auxiliary system.

[0062] In addition to the volumetric flow rate, the ventricular volume 3 is also an interesting parameter. In a complete assist system (only the pump circulates blood), a suction effect or ventricular collapse can occur. In this case, the assist system 2 circulates more blood than flows in from the left atrium. The assist system 2 (or its pump) empties the ventricle. As a result, the ventricular wall approaches the inlet cage and the assist system 2 (or its pump) can suck itself against the "ventricular wall". If the ventricular blood pressure falls below a value of 50 mmHg, the ventricle may also collapse due to the higher ambient pressure. In this case, the ventricular volume 3 can be used as a control parameter to reduce the output of the assist system 2, in particular by reducing its circulation or pump output, so that a minimum ventricular volume can be guaranteed.

[0063] 5 again shows in schematic form the described method, in which the steps of a) determining a first impedance parameter at a first time point by the auxiliary system 2, b) determining a second impedance parameter at a second time point by the auxiliary system 2, and c) using at least the first impedance parameter and the second impedance parameter to determine a change in the impedance parameter or comparing at least the first or second impedance parameter to a threshold value are performed successively.

[0064] The solution proposed here allows in particular one or more of the following advantages: Allows the use of sensors tightly integrated into the assist system, e.g., no separate ultrasound cuff around the aorta is required. · This method allows the determination of the total cardiac time volume as well as the level of assistance (the percentage of pump volumetric flow of the total cardiac time volume). The integration of electrical impedance measurement technology is easier to implement compared to aortic ultrasound cuffs or similar. · Because total cardiac time volume is continuously measured by the system, the LVAD can be adjusted based on both cardiac time volume as well as the level of support, which is particularly advantageous in short-term support systems (keyword weaning). The method determines the ventricular volume so that the assist system can be adjusted, for example, when the minimum ventricular volume is not reached.

Claims

1. An implantable ventricular assist system (2), comprising: a measurement device (9) configured to determine a first impedance parameter at a first time point and a second impedance parameter at a second time point; a processing unit (8) configured to determine a change between the first impedance parameter and the second impedance parameter and to determine a change in a ventricular volume based on the change between the first impedance parameter and the second impedance parameter, the measuring device (9) comprises at least two electrodes (4, 5) that can be used for impedance measurements to determine the first and second impedance parameters, the electrodes being intended to measure ventricular impedance arranged circumferentially on the outer surface of the assist system, The assist system, wherein the processing unit is further configured to compare the first and / or second impedance parameters to a threshold associated with a risk of ventricular collapse, suction of the ventricular assist system into the ventricular wall, or excessive dilation of the ventricular wall.

2. 2. An auxiliary system according to claim 1, wherein the measuring device (9) comprises four electrodes (4, 5, 27, 28) capable of measuring impedance.

3. 3. An auxiliary system according to claim 1 or 2, wherein the measuring device (9) is designed for impedance measurements at different frequencies.

4. The auxiliary system according to any one of claims 1 to 3, further comprising a cannula (13) for supplying a fluid and a flow machine (14, 16) for generating a fluid flow.

5. 5. The auxiliary system of claim 4, wherein the electrodes are arranged circumferentially on an outer surface of the cannula (13) of the auxiliary system.

6. Assist system according to any one of claims 1 to 5, wherein the electrodes (4, 5, 27, 28) are in an implanted state positioned in the ventricular (20) region of the heart.

7. An auxiliary system according to any one of the preceding claims, further comprising a device for determining a fluid volume flow rate (7).

8. 2. The assist system of claim 1, wherein the processing unit is further configured to determine a first ventricular volume based on the first impedance parameter and to determine a second ventricular volume based on the second impedance parameter.

9. 2. The assist system of claim 1, wherein the ventricular assist system includes a cannula for supplying fluid to the ventricular assist system, the cannula having an inlet opening, a first electrode of the at least two electrodes being arranged upstream of the inlet opening on an outer surface of the assist system, and a second electrode of the at least two electrodes being arranged downstream of the inlet opening on an outer surface of the assist system.

10. An implantable ventricular assist system (2), comprising: a measurement device (9) configured to determine a first impedance parameter at a first time point and a second impedance parameter at a second time point; a processing unit (8) configured to determine a change between the first impedance parameter and the second impedance parameter and to determine a change in a ventricular volume based on the change between the first impedance parameter and the second impedance parameter, the measuring device (9) comprises at least two electrodes (4, 5) that can be used for impedance measurements to determine the first and second impedance parameters, the electrodes being intended to measure ventricular impedance arranged circumferentially on the outer surface of the assist system, The ventricular assist system (2) includes a cannula (13) for supplying fluid to the ventricular assist system (2), the cannula having an inlet opening (12), a first electrode (4) of the at least two electrodes (4, 5) being arranged upstream of the inlet opening (12) on an outer surface of the assist system (2) and a second electrode (5) of the at least two electrodes (4, 5) being arranged downstream of the inlet opening (12) on the outer surface of the assist system (2).

Images